Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4256-4259

  Blackard, Jason T ^a   Ma, Gang ^a   Limketkai, Berkeley N ^a   Welge, Jeffrey A ^a   Dryer, Peter D ^a   Martin, Christina M ^a   Hiasa, Yoichi ^b   Taylor, Lynn E ^c   Mayer, Kenneth H ^c   Jamieson, Denise J ^d   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c BROWN UNIVERSITY   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIFE CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT SELECTION; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS MUTATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CD4 LYMPHOCYTE COUNT; FEMALE; GENETIC VARIATION; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 78049494410     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01613-10     Document Type: Article

References (21)

1. Blackard, J., Y. Yang, P. Bordoni, K. Sherman, and R. Chung for the AIDS Clinical Trials Group 383 Study Team. 2004. Hepatitis C virus (HCV) diversity in HIV-HCV coinfected subjects initiating highly active antiretroviral therapy. J. Infect. Dis. 189:1472-1481.
2. Chung, R., J. Andersen, P. Volberding, G. Robbins, T. Liu, K. Sherman, M. Peters, M. Koziel, A. Bhan, B. Alston, D. Colquhoun, T. Nevin, G. Harb, and C. van der Horst for the AIDS Clinical Trials Group A5071 Study Team. 2004. Peginterferon alpha-2a plus ribavirin versus interferon alpha-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N. Engl. J. Med. 351:451-459.
3. Cline, J., J. Braman, and H. Hogrefe. 1996. PCR fidelity of Pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res. 24:3546-3551. (Pubitemid 26315766)
4. Dryer, P. D., B. N. Limketkai, C. M. Martin, G. Ma, K. E. Sherman, L. E. Taylor, K. H. Mayer, D. J. Jamieson, and J. Blackard. 2009. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment naïve women. J. Antimicrob. Chemother. 64:945-948.
5. Hamano, K., N. Sakamoto, N. Enomoto, N. Izumi, Y. Asahina, M. Kurosaki, E. Ueda, Y. Tanabe, S. Maekawa, J. Itakura, H. Watanabe, S. Kakinuma, and M. Watanabe. 2005. Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy. J. Gastroenterol. Hepatol. 20:1401-1409.
6. Itakura, J., K. Nagayama, N. Enomoto, K. Hamano, N. Sakamoto, L. J. Fanning, E. Kenny-Walsh, F. Shanahan, and M. Watanabe. 2005. Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin. J. Viral Hepat. 12:594-603.
7. Layden-Almer, J. E., C. Kuiken, R. M. Ribeiro, K. J. Kunstman, A. S. Perelson, T. J. Layden, and S. M. Wolinsky. 2005. Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients. J. Infect. Dis. 192:1078-1087.
8. Le Pogam, S., A. Seshaadri, A. Kosaka, S. Chiu, H. Kang, S. Hu, S. Rajyaguru, J. Symons, N. Cammack, and I. Nájera. 2008. Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients. J. Antimicrob. Chemother. 61:1205-1216.
9. Lévêque, V. J., and Q. Wang. 2002. RNA-dependent RNA polymerase encoded by hepatitis C virus: biomedical applications. Cell. Mol. Life Sci. 59:909-919.
10. Lohmann, V., A. Roos, F. Körner, J. O. Koch, and R. Bartenschlager. 2000. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J. Viral Hepat. 7:167-174.
11. Perez-Olmeda, M., M. Nunez, M. Romero, J. Gonzalez, A. Castro, J. Arribas, J. Pedreira, P. Barreiro, J. Garcia-Samaniego, L. Martin-Carbonero, I. Jimenez-Nacher, and V. Soriano. 2003. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17:1023-1028. (Pubitemid 36549714)
12. Pond, S. L., and S. Frost. 2005. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21:2531-2533.
13. Qin, H., N. J. Shire, E. D. Keenan, S. D. Rouster, M. E. Eyster, J. J. Goedert, M. J. Koziel, and K. E. Sherman. 2005. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105:533-541.
14. Sherman, K. E., S. D. Rouster, S. Stanford, J. T. Blackard, N. Shire, M. Koziel, M. Peters, and R. T. Chung for the ACTG 5071 Study Team. 2010. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV coinfected subjects treated with interferon-based regimens. J. Infect. Dis. 201:712-719.
15. Shire, N. J., P. S. Horn, S. D. Rouster, S. Stanford, M. E. Eyster, and K. E. Sherman. 2006. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology 44:1146-1157.
16. Simmonds, P. 2004. Genetic diversity and evolution of hepatitis C virus: 15 years on. J. Gen. Virol. 85:3173-3188.
17. Smith, D., D. Warrne, D. Vlahov, P. Schuman, M. Stein, B. Greenberg, and S. Holmberg for the Human Immunodeficiency Virus Epidemiology Research Study Group. 1997. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) study: a prospective cohort of human immunodeficiency virus infection in US women. Am. J. Epidemiol. 146:459-469.
18. Sullivan, D. G., D. Bruden, H. Deubner, S. McArdle, M. Chung, C. Christensen, T. Hennessy, C. Homan, J. Williams, B. J. McMahon, and D. Gretch. 2007. Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. J. Infect. Dis. 196:239-248.
19. Tedaldi, E., R. Baker, A. Moorman, C. Alzola, J. Furhrer, R. McCabe, K. Wood, and S. Holmberg for the HIV Outpatient Study (HOPS) Investigators. 2003. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 36:363-367.
20. Torres-Puente, M., M. Bracho, N. Jiminez, I. Garcia-Robles, A. Moya, and F. Gonzalez-Candelas. 2003. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J. Gen. Virol. 84:2343-2350.
21. Yokozaki, S., J. Takamatsu, I. Nakano, Y. Katano, H. Toyoda, K. Hayashi, T. Hayakawa, and Y. Fukuda. 2000. Immunological dynamics in hemophiliac patients infected with hepatitis C and human immunodeficiency virus: influence of antiretroviral therapy. Blood 96:4293-4299.